Abiopharma

News list

(99% Neutral) AVITA MEDICAL, INC. (RCEL) Announces Regulatory Update

Full text

News bot May 1, 2026, 8:55 p.m.
📋 AVITA MEDICAL, INC. (RCEL) - Regulatory Update

Filing Date: 2026-05-01

Accepted: 2026-05-01 16:54:15

Event Type: Regulatory Update

Event Details:

AVITA MEDICAL, INC. (RCEL) Announces Regulatory Update AVITA MEDICAL, INC. (RCEL) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • Applications: NDA (New Drug Application) • Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency) • Status: Approved, Rejected Clinical Development:
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: AVITA MEDICAL, INC.
- Ticker Symbol: RCEL